US20200237534A1 - Magnetic stent and stent delivery - Google Patents

Magnetic stent and stent delivery Download PDF

Info

Publication number
US20200237534A1
US20200237534A1 US16/752,315 US202016752315A US2020237534A1 US 20200237534 A1 US20200237534 A1 US 20200237534A1 US 202016752315 A US202016752315 A US 202016752315A US 2020237534 A1 US2020237534 A1 US 2020237534A1
Authority
US
United States
Prior art keywords
stent
magnetic
hollow tubular
tubular section
node
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US16/752,315
Other versions
US11666464B2 (en
Inventor
Spiros Manolidis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tensor Flow Ventures LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from US16/752,343 external-priority patent/US20200237540A1/en
Priority to US16/752,343 priority Critical patent/US20200237540A1/en
Priority to US16/752,315 priority patent/US11666464B2/en
Priority to US16/752,265 priority patent/US20200237539A1/en
Priority to PCT/US2020/015444 priority patent/WO2020160011A1/en
Priority to CN202080024771.8A priority patent/CN113727679A/en
Priority to PCT/US2020/015439 priority patent/WO2020160008A1/en
Priority to EP20749110.1A priority patent/EP3917460A4/en
Priority to EP20749551.6A priority patent/EP3917462A4/en
Priority to CN202080024710.1A priority patent/CN113727677A/en
Priority to JP2021543526A priority patent/JP2022518579A/en
Priority to EP20748013.8A priority patent/EP3917459A4/en
Priority to CN202080025337.1A priority patent/CN113727678A/en
Priority to JP2021543525A priority patent/JP2022520164A/en
Priority to JP2021566434A priority patent/JP2022520131A/en
Priority to PCT/US2020/015447 priority patent/WO2020160013A1/en
Publication of US20200237534A1 publication Critical patent/US20200237534A1/en
Assigned to TENSOR FLOW VENTURES LLC reassignment TENSOR FLOW VENTURES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANOLIDIS, SPIROS
Assigned to TENSOR FLOW VENTURES LLC reassignment TENSOR FLOW VENTURES LLC CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 16725315 PREVIOUSLY RECORDED AT REEL: 056738 FRAME: 0936. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Assignors: MANOLIDIS, SPIROS
Priority to US18/205,895 priority patent/US20230310184A1/en
Publication of US11666464B2 publication Critical patent/US11666464B2/en
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6862Stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/009Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A stent apparatus for use in surgical applications having a hollow tubular section with a proximal end and a distal end. Additionally, the stent apparatus can have at least one anchor point connected to the hollow tubular section. The hollow tubular section may also have a modifiable member, and a magnetic connection node. The stent may also be wrapped in a material that has magnetic properties. The delivery of the stent can include a stent delivery tool for inserting a stent into a vessel.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • The present disclosure claims priority to and is a non-provisional conversion of U.S. Provisional Patent Application No. 62/797,933, filed Jan. 28, 2019, and is a continuation-in-part of U.S. patent application Ser. No. 16/752,265 filed Jan. 24, 2020 which claims priority from U.S. Provisional Patent Application No. 62/797,932, filed Jan. 28, 2019, and is a continuation-in-part of U.S. patent application Ser. No. ______, filed Jan. 24, 2020 which claims priority from U.S. Provisional Patent Application No. 62/797,944, filed Jan. 28, 2019, all of which is incorporated herein by reference in its entirety for all purposes.
  • BACKGROUND Technical Field
  • The present disclosure relates to stents and stent delivery. More particularly, and not by way of limitation, the present disclosure is directed to an apparatus, method, or system for a magnetic stent and magnetic stent delivery.
  • Description of Related Art
  • There are many different types of surgeries that can be conducted daily in hospitals across the world. One such surgery is free flap reconstruction. Free flap reconstruction is a well-established method of reconstruction of both soft tissue and bone or composite defects in a wide variety of surgeries. Free flaps are used in order of frequency in head and neck reconstruction, breast reconstruction, orthopedic surgery and a variety of other specialties. Head and neck surgery in particular is a heavy user of free flap reconstruction. This is due to the complexity of defects in a critical area where restoration of functions such as deglutition, phonation, and mastication is of paramount importance in addition to cosmesis.
  • Free flap reconstruction involves the transfer of tissue from a distant part of the body to the area that needs to be reconstructed. The principle in operation behind this concept is that tissues in the body are supplied in a segmental function. That is that a segment of skin subcutaneous tissue fascia muscle bone or any combination of these can be harvested according to specific location. The transfer of tissue is completed when the free flap vessels (artery and vein) are joined to the donor vessels and then the flap is set into the defect.
  • Donor vessels are selected from appropriate vessels to match the diameter of the recipient vessels (free flap vessels). In the neck, these are usually branches of the external carotid artery and one of the many veins in the head and neck or the jugular vein itself. Each of the donor vessels are dissected from surrounding tissue, and their edges prepared for anastomosis. In free flap reconstruction, vessels are raised in situ and the vascular supply is dissected out carefully and atraumatically. The vascular supply is then sectioned, preferably at a length of vessel that is appropriate for an anastomosis without tension. This is not always possible as different free flaps have different lengths of vessels according to where they are harvested. For example, free rectus vascular pedicle may have a max length of 8 cm, while radial forearm vascular pedicle may have a max length of 15-20 cm.
  • Once the vessels are extracted from the appropriate location, the edge preparation begins. The vessel preparation process can take approximately one hour and is performed under optimal conditions with an operating microscope and/or magnifying loops. Considerable skill is required that comes with prolonged surgical training. The anastomoses (joining) themselves are approximately 20 minutes per vessel anastomosis. Venous couplers reduce the amount of time required for venous anastomoses. However, these venous couplers still require suturing for each venous anastomoses, taking considerable time and increasing the time a patient is under anesthesia. There are two general types of anastomoses, an end to end and an end to side. An end-to-end anastomoses is preferred because it is performed rapidly without additional problems and because the vascular dynamics are that of linear flow which gives lesser complication rates. End to end anastomoses account for the majority of vessel joining. However, currently these operations and/or couplings still require significant suturing time, that can lead to other complications. Furthermore, manually suturing vessels, especially in micro vascular surgery is where most of the technical failures occur.
  • It would be advantageous to have an apparatus, system, or method for a magnetic stent and magnetic stent delivery that overcomes the disadvantages of the prior art. The present disclosure provides such a system and method.
  • BRIEF SUMMARY
  • The present invention is directed to a stent and delivery of said stent during open surgery. Thus, in one aspect, the present invention is directed to a stent that may self-modify, or self-expand during or upon delivery or after delivery.
  • In another aspect, the present invention is directed to a stent that may be delivered with an outer sheath or protective layer. In yet another aspect, the present invention is directed to a stent that may be delivered through a syringe or push release mechanism utilizing magnetic forces.
  • Therefore, in one aspect, the present invention is directed to a modified self-expanding stent that expands based on magnetic forces. The stent may have anchor points or atraumatic points.
  • Thus, in one aspect, the present invention is directed to rapidly performing anastomoses without vessel preparation or suturing. In another aspect, the present invention is directed to lengthening the pedicle during grafts and/or distention of the lumen of the vessel during stent operation.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The novel features believed characteristic of the disclosure are set forth in the appended claims. The disclosure itself, however, as well as a preferred mode of use, further objectives and advantages thereof, will be best understood by reference to the following detailed description of illustrative embodiments when read in conjunction with the accompanying drawings, wherein:
  • FIG. 1A is an illustration of a magnetic stent coupled to a donor and recipient vessel.
  • FIG. 1B is an illustration of a magnetic stent with expansion cover coupled to a donor and recipient vessel.
  • FIG. 2 is an illustration of an expansion cover.
  • FIG. 3A is an illustration of a magnetic stent and donor vessel.
  • FIG. 3B is an illustration of a magnetic stent, donor and recipient vessels.
  • FIG. 3C is an illustration of an expanded magnetic stent, donor and recipient vessels.
  • FIG. 4A is an illustration of an alternative expansion cover.
  • FIG. 4B is an illustration of an alternative expansion cover.
  • FIG. 5A is an illustration of a magnetic stent in a longitudinal or end view.
  • FIG. 5B is an illustration of a magnetic stent in a side view.
  • FIG. 6 is an illustration of a magnetic expansion structure.
  • FIG. 7A is an illustration of a magnetic stent in an unexpanded state in a longitudinal or end view.
  • FIG. 7B is an illustration of a magnetic stent in an expanded state in a longitudinal or end view.
  • FIG. 8 is an illustration of a magnetic connection node.
  • FIG. 9 is an illustration of a magnetic connection node.
  • FIG. 10 is an illustration of a magnetic stent.
  • FIG. 11A is an illustration of an expandable magnetic structure for a magnetic stent in a side view.
  • FIG. 11B is an illustration of an expandable magnetic structure for a magnetic stent in a longitudinal or end view.
  • FIG. 12A is an illustration of a magnetic stent in an unexpanded state.
  • FIG. 12B is an illustration of a magnetic stent in a partially expanded state.
  • FIG. 12C is an illustration of a magnetic stent in a fully expanded state.
  • FIG. 13 is an illustration of a magnetic stent in a fully expanded state.
  • DETAILED DESCRIPTION
  • An embodiment of the disclosure will now be described.
  • FIG. 1A is an illustration of a magnetic stent 100A coupled to a donor vessel 104 and a recipient vessel 106. While the magnetic stent 100A may also have additional regions, and/or expansion regions the magnetic expansion region 108 allows the magnetic stent 100A to expand in a controlled manner. The stent body 102 can include the magnetic expansion region 108, connection node(s) 110, and/or expandable member(s) 112. In at least one version, the magnetic expansion region 108 is triggered by a magnetic, electric, and/or electromagnetic field. The expansion and/or transition of the magnetic expansion region 108 can also cause the expandable member(s) 112 to transition or expand as well.
  • FIG. 1B is an illustration of a magnetic stent 100B coupled to a donor vessel 104 and a recipient vessel 106 and covered with an expansion cover 114. The expansion cover 114 in at least one version provides a magnetic field that prevents and/or activates the expansion of the magnetic stent 100B. In other versions, the expansion cover 114 activates the expansion of a magnetic expansion region of the magnetic stent 100B. The magnetic stent 100B can have a stent body 102 that defines a hollow tubular section 101 having a distal end 103 and proximal end 105. The stent body 102 can also include connection node(s) 110, and/or expandable member(s) 112.
  • FIG. 2 is an illustration of an expansion cover 214. The expansion cover 214 can contain magnetic material 216, sensor(s) 218, wiring 220, coupling material 222, and/or removal device(s) 224. The cover body 226 can be manufactured and/or formed from fabrics, plastics, alloys, metals, synthetics, and/or combinations thereof. The fabrics, plastics, alloys, metals, synthetics, and/or combinations thereof can be impregnated or contain a magnetic material or magnetic material or elements 216 having magnetic properties that assist in the activation and/or deactivation of the magnetic expansion region. In at least one example, the materials utilized may have an expansion memory property that allows for repeatable changes to the material. The expansion cover 214 may also in at least one version, activate or deactivate additional expansion regions of a stent (not illustrated). The sensor(s) 218, in at least one version would include a blood flow sensor. In other versions, the sensor(s) 218 may also include pulse, blood pressure, temperature, accelerometer, blood glucose, oxygen, airflow, galvanic skin response, electrocardiogram, similar sensors or monitors, or combinations thereof. The wiring 220 can allow the sensor(s) 218 to connect to sensors, monitors, computers, processors, communication devices, transmitters, and/or receivers. The coupling material 222 can allow the expansion cover 214 to be coupled to a removal device 224, and/or secured within, around, and/or near a vessel and/or tissue. The removal device 224 can include a needle, and/or a syringe.
  • FIG. 3A is an illustration of a magnetic stent 300A and a donor vessel 304. The magnetic stent 300A can have a stent body 302 that defines the hollow structure (not illustrated) that allows for a fluidic transfer, such as, but not limited to a blood flow 330, from a first opening 307 of the magnetic stent 300A to a second opening 309 of the magnetic stent 300A. In at least one version, the magnetic stent 300A has a magnetic expansion region 308 that can expand, contract, and/or compress based on a magnetic field created by an expansion cover 314. The expansion cover 314 can include magnetic materials and/or elements that can be activated and/or deactivated by sensor(s) or other monitoring devices coupled to the expansion cover 314 via a wired or wireless connection.
  • Additionally, the stent body 302 can also include connection node(s) 310, magnetic node(s) 311, and/or expandable member(s) 312. The expandable member(s) 312 may be manufactured and/or formed from plastics, silicon, metal, metal alloys, synthetic materials, polymers, absorbable polymers, Teflon, Mylar, carbon fiber, magnetic materials or elements, other like materials, or combinations thereof. In at least one embodiment, the expandable member(s) may also be a modifiable member. The material should have a compressibility that allows for the expandable member(s) 312 to be approximately one-half its normal size, be approximately one-quarter of its normal size, or any other fraction of one whole portion of the expandable member(s) 312. The expandable member(s) 312 may also be formed, constructed, and/or manufactured utilizing a material that may have a memory effect such as a pliable plastic or silicon material, but other materials such as plastics, silicon, metal, metal alloys, synthetic materials, polymers, absorbable polymers, Teflon, Mylar, carbon fiber, other like materials, or combinations thereof, may also be utilized. A memory effect can be described as a material that can be manipulated from a first position to a second position and then return to the first position upon release from the second position.
  • The connection node(s) 310 can provide a connection point for the expandable member(s) 312. The connection node(s) 310 may be constructed, formed, or manufactured utilizing a material such as, but not limited to, plastics, silicon, metal, metal alloys, synthetic materials, polymers, absorbable polymers, Teflon, Mylar, carbon fiber, other like materials, or combinations thereof. In one example, the connection node(s) 310 can be constructed, formed, and/or manufactured with the expandable member(s) 312. In alternative examples, the connection node(s) 310 may be connected to, or affixed to the expandable member(s) 312 through an adhesive, fastener, glue, connector, cement, epoxy, binder, or other adhesive or fastening methods or device, or combinations thereof.
  • The magnetic node(s) 311 can provide a connection point for the expandable member(s) 312. The magnetic node(s) 311 may be constructed, formed, or manufactured utilizing a material such as, but not limited to, plastics, silicon, metal, metal alloys, synthetic materials, polymers, absorbable polymers, Teflon, Mylar, carbon fiber, other like materials, or combinations thereof that are impregnated or infused with magnetic materials and/or elements. In at least one example, the magnetic node(s) 311 can be constructed, formed, and/or manufactured with the expandable member(s) 312. In alternative examples, the magnetic node(s) 311 may be connected to, or affixed to the expandable member(s) 312 through an adhesive, fastener, glue, connector, cement, epoxy, binder, or other adhesive or fastening methods or device, or combinations thereof.
  • In at least one version, the magnetic stent 300A and/or stent body 302 can be protected, compressed, and/or contained by a sheath, cover, or transportation device 332. The sheath, cover, or transportation device 332 can be coupled to a needle 334 or other device capable of allowing the sheath, cover, or transportation device 332 to be removed from a vessel and/or tissue.
  • FIG. 3B is an illustration of a magnetic stent 300B, a donor vessel 304 and a recipient vessel 306. The magnetic stent 300B can have a stent body 302 that defines the hollow structure or hollow tubular body (not illustrated) that allows for a fluidic transfer, such as, but not limited to a blood flow 330, from a first opening 307 of the magnetic stent 300B to a second opening 309 of the magnetic stent 300B. In at least one version, the magnetic stent 300B includes a magnetic expansion region 308 that can expand, contract, and/or compress based on the activation and/or deactivation of a magnetic field around and/or through the magnetic expansion region 308. The magnetic stent 300B and/or stent body 302 can also include other expandable region(s) and/or section(s). The magnetic stent 300B and/or stent body 302, in at least one version, include connection node(s) 310, magnetic node(s) 311, and expandable member(s) 312. The nodes 310/311 and expandable member(s) 312 in combination with the magnetic expansion region can provide for the expansion, and/or compression of the magnetic stent 300B and/or stent body 302 and a change of diameter of the magnetic stent 300B and/or stent body 302 from a first diameter 336A to a second diameter illustrated FIG. 3C.
  • A sheath, cover, or transportation device 332 can be removed from surrounding, containing, and/or compressing the magnetic stent 300B and/or stent body 302. In at least one version, the sheath, cover, or transportation device 332 is coupled to a needle 334 or other removal device. In other versions, the sheath, cover, or transportation device 332 and needle 334 are constructed, manufactured, and/or formed from the same material. The needle 334 can create or pass through an opening 338. The opening 338 can created in any number of vessels and/or tissues to allow for the removal of the sheath, cover, or transportation device 332.
  • FIG. 3C is an illustration of an expanded magnetic stent 300C, a donor vessel 304, and a recipient vessel 306. The magnetic stent 300C can have a stent body 302 that defines the hollow structure or hollow tubular body (not illustrated) that allows for a fluidic transfer, such as, but not limited to a blood flow 330, from a first opening of the magnetic stent 300C to a second opening of the magnetic stent 300C.
  • The connection node(s) 310, magnetic node(s) 311, and expandable member(s) 312 can work in combination, and with an expansion cover (not illustrated) to expand, contain, and/or compress the magnetic stent 300C and/or stent body 302. As the magnetic stent 300C and/or stent body 302 is expanded, contained, and/or compressed a second inner diameter 336B can be the result. The sheath, cover, or transportation device 332 can also assist in the expansion, compression, and/or containment of the magnetic stent 300C and/or stent body 302.
  • The magnetic stent 300C and/or stent body 302 can be modified from a first inner diameter illustrated in FIG. 3B to a second inner diameter 336B to allow for a securing of the magnetic stent 300C and/or stent body 302 within the donor and recipient vessels 304/306. The securing can be through anchor(s) 315, and/or interaction with vessels and/or tissue. The anchor(s) can be an anchor point, atraumatic anchor or anchor point, and/or traumatic anchor or anchor point, where a traumatic anchor can puncture or be invasive to a vessel or tissue but would be an acceptable level of injury and/or be minimally invasive to secure the stent in place within the vessel or tissue. The anchor(s) can also be expandable, and/or maintained in a fixed position. In at least one example, the anchor(s) can extend radially from the circumference or outer surface of the magnetic stent 300C and/or stent body 302.
  • FIG. 4A is an illustration of an alternative expansion cover 414A. The expansion cover 414A may also include a magnetic material 416A and/or 416B. The magnetic material 416 (collectively) may be placed in specific location to generate specific expansions, and/or expansion zones for a stent (not illustrated). A sensor 418 can be coupled to wires 420A/420B to allow for a measurement and/or activation signal for the magnetic materials, and/or blood flow, and other measurements.
  • FIG. 4B an illustration of an alternative expansion cover 414B. The expansion cover 414A may also include a magnetic material 416C and/or 416D. The magnetic material 416 (collectively) may be placed in specific location to generate specific expansions, and/or expansion zones for a stent (not illustrated).
  • FIG. 5A is an illustration of a magnetic stent 500A in a longitudinal or end view. The magnetic stent 500A can include multiple magnetic node(s) 511 that can assist in the expansion, compress, and/or containment of the magnetic stent 500A and/or stent body (not illustrated). The magnetic node(s) 511 can be interconnected with expandable member(s) 512. In at least one example, the expandable member(s) 512 can be constructed, manufactured, and/or formed with magnetic materials and/or elements. These magnetic materials and/or elements can include, but are not limited to ferromagnetic materials such as iron nickel, and/or cobalt, alloys, and/or other rare earth metals or minerals. The expansion, compression, and/or containment of the magnetic stent 500A can also be assisted by a sheath, cover, or transportation device 532. The sheath, cover, or transportation device 532 can be constructed, manufactured, and/or formed with materials that prevent the expansion of the expandable member(s) 512, and/or the magnetic node(s) 511, while remaining flexible enough to be removed and/or perforated to ease removal. A needle 534 may also be coupled to the sheath, cover, or transportation device 532 to assist in the removal of the sheath, cover, or transportation device 532 through vessel(s) and/or tissue. The inner diameter 521 of the magnetic stent 500A can be modified by the expansion, compression, and/or containment of the magnetic stent 500A. In at least one version, a magnetic field can be utilized to collapse the magnet stent 500A, around a vessel or stent.
  • FIG. 5B is an illustration of a magnetic stent 500B in a side view. The magnetic stent 500B can have multiple regions, such as, but not limited to, a magnetic expansion region 508, expandable region 509A, and/or expandable region 509B. These regions 508/509A/509B can be expanded, compressed, and/or contained simultaneously and/or individually. The expansion can be triggered by interactions and/or caused by forces acting on the connection node(s) 510, magnetic node(s) 510, and/or expandable member(s) 512 such as, but not limited to a magnetic, electrical and/or electromagnetic force. In at least one example, a magnetic field (not illustrated) can be utilized to modify magnetic expansion region 508 via the magnetic node(s) 511. In other examples, the expandable member(s) 512 and/or connection node(s) 510 can be activated by fields, sensors, and/or monitors, or based on effects caused by a blood flow or fluid flowing through the magnetic stent 500B.
  • FIG. 6 is an illustration of a magnetic node(s) 611 and expandable member(s) 612. The magnetic node(s) 611 can interact with each other individually and/or collectively to trigger or cause an expansion, compression, and/or containment of the expandable member(s) 612. In at least one example, a magnetic field can be generated by an external device or force that can cause the magnetic node(s) 611 to interact, modify, and/or move in response to magnetic field. The interaction, modification, and/or movement can cause the magnetic node(s) 611 to move and/or modify the expandable member(s) 612. For example, a magnetic field could cause the magnetic node(s) 611 to have an attractive force 625A that compresses and/or contains the expandable member(s) at a specific length 627. In other examples, a repulsive force 625B can cause an expansion of the expandable member to a specific length. These forces can also cause other magnetic node(s) 611, connection node(s) (not illustrated) and/or expandable member(s) 612 to also expand, compress, and/or be contained or constrained to specific level or positions.
  • FIG. 7A is an illustration of a magnetic stent 700A in an unexpanded state in a longitudinal or end view. The magnetic stent 700A can be expanded, compressed, and/or contained by a magnetic field, sheath, cover, and/or transport device (not illustrated). In at least one version, the magnetic stent 700A includes magnetic node(s) 711, and expandable members 712. The magnetic stent 700A can also include connection node(s) (not illustrated) and/or non-expandable member(s) (not illustrated). The expandable member(s) 712 can allow for the expansion, compression, and/or containment of the magnetic stent.
  • For example, when the expandable member(s) 712 are in an unexpanded state the magnetic stent 700A can have a first internal radius 731 that in at least one version can be increased. In other versions, the first internal radius can be decreased. The increase/decrease in the radius of the magnetic stent 700A can be caused by an attractive force and/or a repulsive force (not illustrated). The forces can be caused by the poles of magnetic node(s) 711. For example, when the north magnet pole of a first magnetic node is pointed at the south magnet pole of a second magnetic node an attractive force can cause the expandable member to compress between the two magnetic nodes. The length, diameter, and/or size of the magnetic stent 700A can also be modified by the attractive force.
  • FIG. 7B is an illustration of a magnetic stent 700B in an expanded state in a longitudinal or end view. The magnetic stent 700B can be expanded, compressed, and/or contained by a magnetic field, sheath, cover, and/or transport device (not illustrated). In at least one version, the magnetic stent 700B includes magnetic node(s) 711, and expandable members 712. The magnetic stent 700B can also include connection node(s) (not illustrated) and/or non-expandable member(s) (not illustrated). The expandable member(s) 712 can allow for the expansion, compression, and/or containment of the magnetic stent 700B.
  • For example, when the expandable member(s) 712 are in an expanded state the magnetic stent 700B can have a second internal radius that in at least one version can be decreased. In other versions, the second internal radius can be further increased. The increase/decrease in the radius of the magnetic stent 700B can be caused by an attractive force (not illustrated) and/or a repulsive force. The forces can be caused by the poles of magnetic node(s) 711. For example, when the north magnet pole of a first magnetic node is pointed at the north magnet pole of a second magnetic node a repulsive force can cause the expandable member to expand between the two magnetic nodes. In another example, the expandable member(s) 712 can be manufactured with magnetic materials or elements that can be attracted and/or repulsed by the magnetic node(s) 711 and/or a magnetic field (not illustrated). In yet another example, the magnetic node(s) 711 can have their magnetic strength modified by sensor(s), monitor(s), and/or a fluid flow through the magnetic stent 700B.
  • FIG. 8 is an illustration of a magnetic node 811. The magnetic node 811 in at least one version, can be created, constructed, and/or manufactured with magnetic materials, elements, and/or electromagnetic windings. A winding 840 can be utilized to create the coil surrounding a core for an electromagnet for the magnetic node 811. In at least one example, the core would be ferromagnetic metal such as iron or ferrimagnetic compounds. In other examples, the core could include steel, laminated silicon steel, laminated cores and/or sheets, silicon alloys, other allows, vitreous metals, powdered metals such as iron, carbonyl iron, hydrogen-reduced iron, molypermalloy, nickle-iron, sendust, KoolMU, nanocrystalline, and/or ferrites and/or air. The winding 840 can be utilized with an electrical connection 842 to provide a voltage and/or current to the winding 840 that initiates a corresponding magnetic field. In at least one example, the electrical filed or energies may come from the natural fields or energy of the human body. The voltage and/or current applied to the winding 840 can cause a first magnetic pole 844A and a second magnetic pole 844B to be created. In at least one example, the first magnetic pole 844A is a north magnetic pole and the second magnetic poly 844B is a south magnetic pole. In other examples, the voltage and/or current polarity is reversed and the magnetic field is also reversed casing the first magnetic pole 844A to be a south magnetic pole and the second magnetic pole 844B is a north magnetic pole.
  • FIG. 9 is an illustration of a magnetic node 911. The magnetic node 911 in at least one version, can be created, constructed, and/or manufactured with magnetic materials, elements, and/or electromagnetic windings. A winding 940 can be utilized to create the coil for an electromagnet for the magnetic node 911. The winding 940 when utilized with an electrical connection (not illustrated) that can provide a voltage and/or current to the winding 940 to generate the corresponding magnetic field. The voltage and/or current applied to the winding 940 cause a north magnetic pole 944A and a south magnetic pole 944B to be created. In at least one example, a current flows in a first direction 941 through the winding 940 creating the north magnetic pole, and the south magnetic pole. In other examples, the voltage and/or current polarity can be reversed and the corresponding magnetic field reversed causing the north magnetic pole to become a south magnetic pole, and the south magnetic pole to become a north magnetic pole.
  • FIG. 10 is an illustration of a magnetic stent 1050. In at least one version, the magnetic stent 1050 can have at least one anchor 1052 along the inner circumference 1051 of the magnetic stent 1050. In other versions, the anchor(s) 1052 can also be placed along the outer circumference of the magnetic sent 1050. A first magnetic node 1054A can interact with a second magnetic node 1054B to expand, contract, compress, and/or contain the magnetic stent 1050. The magnetic nodes 1054A/1054B can each have a north magnetic pole 1056A, and a south magnetic pole 1056B that are separated by a winding 1058. Based on the polarity of the magnetic poles 1056A/1056B a force 1060 is created that attracts or repulses the magnetic nodes 1054A/1054B from one another, and opening or closing the magnetic stent 1050. For example, the magnetic stent 1050 can be utilized for a surgery that requires the stent to seal the outer surface of a vessel and/or portion of tissue. In other examples, the magnetic stent 1050 is utilized for heart operations to open a vessel and/or portion of tissue to increase the blood flow through and/or to a specific region.
  • FIG. 11A is an illustration of an expandable magnetic structure for a magnetic stent in a side view. A magnetic stent (not illustrated) can include connection node(s) 1110, magnetic node(s) 1111, expandable member(s) 1112, and/or non-expandable members 1161. The members 1112/1161 can be constructed and/or manufactured of varying lengths and thicknesses. With varying lengths, the expandable member(s) 1112 can allow a stent to be configured for any number of cross-sections, expansions, compressions, and/or profiles. A combination of connection node(s) 1110, and non-expandable member(s) also assist in creating any number of cross-sections, and/or profiles for a stent. In at least one example, the non-expandable members may also be structural member(s).
  • FIG. 11B is an illustration of an expandable magnetic structure for a magnetic stent in a partial longitudinal or end view. A magnetic stent (not illustrated) can include connection node(s) 1110, magnetic node(s) 1111, expandable member(s) 1112, and/or non-expandable members 1161. The members 1112/1161 can be constructed and/or manufactured of varying lengths and thicknesses. With varying lengths, the expandable member(s) 1112 can allow a stent to be configured for any number of cross-sections, and/or profiles. A combination of connection node(s) 1110, and non-expandable member(s) also assist in creating any number of cross-sections, and/or profiles for a stent. In at least one example, an anchor or set of anchor(s) may also be coupled to the connection node(s) 1110, magnetic node(s) 1111, expandable member(s) 1112, and/or non-expandable member(s).
  • FIG. 12A is an illustration of a magnetic stent 1200A in an unexpanded state. The magnetic stent 1200A includes a stent body 1202 that can define a hollow tubular structure with a first opening at a proximal end of the stent body 1202 and/or hollow tubular structure and a second opening at a distal end of the stent body 1202 and/or hollow tubular structure. A donor vessel 1204, and/or recipient vessel 1206 can surround, and/or be contained by a magnetic stent 1200A.
  • FIG. 12B is an illustration of a magnetic stent 1200B in a partially expanded state. The magnetic stent 1200B can include anchor(s) 1203A at the proximal end and anchor(s) 1203B at the distal end, and/or along the outer surface of the magnetic stent 1200B. The anchor(s) 1203A/1203B can interface with the inner and/or outer surface of a vessel, such as, but not limited to, a donor vessel 1204, recipient vessel 1206, or other tissue to secure the magnetic stent 1200B in place. A stent delivery tool 1299 may also allow for the insertion and/or placement of the magnetic stent 1200B. In at least one example, the stent delivery tool 1299 may also include magnetic properties that allow for the expansion and/or activation of the expansion based on the positional relationship of the stent delivery tool 1299 and/or the magnetic stent 1200B.
  • For example, the magnetic stent 1200B may be constructed of expandable and/or non-expandable structures, such as, but not limited to member(s) and/or connection node(s) infused, impregnated or including magnetic materials or elements. The magnetic materials or elements allow the magnetic stent to expand, compress, or contain a vessel or tissue to a specified diameter, profile, and/or cross-section. The magnetic stent 1200B may be expanded, compressed, and/or contained in individual sections or regions, or as a single stent, or in a combination of sections or regions.
  • FIG. 12C is an illustration of a magnetic stent 1200C in a fully expanded state. When the magnetic stent 1200C is in a fully expanded state, it can allow for an increased state of blood flow or other fluids through the stent body 1202. In at least one example, the magnetic stent 1200C includes anchor(s) 1203A, and 1203B that can be atraumatic or traumatic anchors. The anchor(s) 1203A/1203B can be expandable or transferable, and/or held in a fixed position. The anchor(s) 1203A can interface and/or couple to a vessel and/or tissue at an interface point 1271. Similarly, anchor(s) 1203B can interface and/or couple to a vessel and/or tissue at an interface point.
  • FIG. 13 is an illustration of a magnetic stent 1300 in a fully expanded state. The magnetic stent 1300 in a fully expanded state can have an inner diameter 1362 that in at least one version can be reduced. The outer surface 1366 of the magnetic stent 1300 can include a smooth outer surface, a textured surface, and/or anchor(s) 1364 coupled to the outer surface 1366. The anchor(s) 1364 can be atraumatic and/or traumatic. In at least one version, the anchor(s) 1364 extend radially from the outer surface 1366, and at either end of the magnetic stent 1300. In other versions, the anchor(s) 1364 may be placed along the length of the magnetic stent 1300, in equally spaced position, or unequally spaced positions.
  • While this disclosure has been particularly shown and described with reference to preferred embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend the invention to be practiced otherwise than as specifically described herein. Accordingly, this disclosure includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the disclosure unless otherwise indicated herein or otherwise clearly contradicted by context.
  • While various embodiments in accordance with the principles disclosed herein have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of this disclosure should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with any claims and their equivalents issuing from this disclosure. Furthermore, the above advantages and features are provided in described embodiments, but shall not limit the application of such issued claims to processes and structures accomplishing any or all of the above advantages.
  • Additionally, the section headings herein are provided for consistency with the suggestions under 37 C.F.R. 1.77 or otherwise to provide organizational cues. These headings shall not limit or characterize the invention(s) set out in any claims that may issue from this disclosure. Specifically, and by way of example, although the headings refer to a “Technical Field,” the claims should not be limited by the language chosen under this heading to describe the so-called field. Further, a description of a technology as background information is not to be construed as an admission that certain technology is prior art to any embodiment(s) in this disclosure. Neither is the “Brief Summary” to be considered as a characterization of the embodiment(s) set forth in issued claims. Furthermore, any reference in this disclosure to “invention” in the singular should not be used to argue that there is only a single point of novelty in this disclosure. Multiple embodiments may be set forth according to the limitations of the multiple claims issuing from this disclosure, and such claims accordingly define the embodiment(s), and their equivalents, that are protected thereby. In all instances, the scope of such claims shall be considered on their own merits in light of this disclosure, but should not be constrained by the headings set forth herein.

Claims (24)

We claim:
1. A stent apparatus for use in surgical applications, comprising:
a hollow tubular section with a proximal end and a distal end;
at least one anchor point connected to the hollow tubular section;
wherein the hollow tubular section is comprised of at least one modifiable member; and
wherein the hollow tubular section is comprised of at least one magnetic connection node.
2. The stent apparatus of claim 1, wherein the proximal end has at least one atraumatic anchor point.
3. The stent apparatus of claim 1, wherein the proximal end has at least one traumatic anchor point.
4. The stent apparatus of claim 1, wherein the distal end has at least one atraumatic anchor point.
5. The stent apparatus of claim 1, wherein the distal end has at least one traumatic anchor point.
6. The stent apparatus of claim 1, wherein the at least one modifiable member comprises a material that is modifiable by a magnetic field.
7. The stent apparatus of claim 1, wherein the at least one modifiable member has expansion memory.
8. The stent apparatus of claim 1, wherein the at least one modifiable member is connected to form a circumference of the proximal end.
9. The stent apparatus of claim 1, wherein the at least one modifiable member is connected to form a circumference of the distal end.
10. The stent apparatus of claim 1, wherein the at least one modifiable member is connected to form a circumference of the hollow tubular section.
11. The stent apparatus of claim 1, wherein the hollow tubular section is further comprised of at least one structural member.
12. The stent apparatus of claim 11, wherein the at least one structural member is connected to the at least on modifiable member by the at least one magnetic connection node.
13. The stent apparatus of claim 11, wherein the hollow tubular section is further comprised of at least one connection node.
14. The stent apparatus of claim 13, wherein the at least one modifiable member is connected by the at least one magnetic connection node, and the at least one connection node.
15. The stent apparatus of claim 1, wherein the hollow tubular section further comprises at least one atraumatic anchor extending radially from the hollow tubular section.
16. The stent apparatus of claim 1, wherein the hollow tubular section further comprises at least one traumatic anchor extending radially from the hollow tubular section.
17. The stent apparatus of claim 1, wherein the hollow tubular section further comprises at least one sensor.
18. The stent apparatus of claim 17, wherein the at least one sensor is a blood flow sensor.
19. The stent apparatus of claim 1, wherein the stent apparatus further comprises a stent wrapping.
20. An apparatus to wrap a stent, comprising:
a first material and a second material; and
wherein the second material has magnetic properties.
21. The apparatus of claim 20, wherein the apparatus further comprises a sensor coupled to the second material.
22. The apparatus of claim 20, wherein the apparatus further comprises a third material.
23. The apparatus of claim 22, wherein the third material has properties that prevents a magnetic field from reaching the second material.
24. A system for stent delivery in surgical applications, comprising:
a stent delivery tool for inserting a stent into a vessel, the stent delivery comprising:
wherein the stent comprises a hollow tubular section with a proximal end and a distal end;
at least one anchor point connected to the hollow tubular section;
wherein the hollow tubular section is comprised of at least one modifiable member; and
wherein the hollow tubular section is comprised of at least one magnetic connection node.
US16/752,315 2019-01-28 2020-01-24 Magnetic stent and stent delivery Active US11666464B2 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
US16/752,343 US20200237540A1 (en) 2019-01-28 2020-01-24 Stent delivery for vascular surgery
US16/752,315 US11666464B2 (en) 2019-01-28 2020-01-24 Magnetic stent and stent delivery
US16/752,265 US20200237539A1 (en) 2019-01-28 2020-01-24 Stent and stent delivery for vascular surgery
EP20748013.8A EP3917459A4 (en) 2019-01-28 2020-01-28 Magnetic stent and stent delivery
JP2021543525A JP2022520164A (en) 2019-01-28 2020-01-28 Improved stent delivery for vascular surgery
PCT/US2020/015439 WO2020160008A1 (en) 2019-01-28 2020-01-28 Stent and stent delivery for vascular surgery
EP20749110.1A EP3917460A4 (en) 2019-01-28 2020-01-28 Stent and stent delivery for vascular surgery
EP20749551.6A EP3917462A4 (en) 2019-01-28 2020-01-28 Improved stent delivery for vascular surgery
CN202080024710.1A CN113727677A (en) 2019-01-28 2020-01-28 Magnetic stent and stent delivery
JP2021543526A JP2022518579A (en) 2019-01-28 2020-01-28 Stents and stent delivery for vascular surgery
PCT/US2020/015444 WO2020160011A1 (en) 2019-01-28 2020-01-28 Magnetic stent and stent delivery
CN202080025337.1A CN113727678A (en) 2019-01-28 2020-01-28 Stent and stent delivery for vascular surgery
CN202080024771.8A CN113727679A (en) 2019-01-28 2020-01-28 Improved stent delivery for vascular surgery
JP2021566434A JP2022520131A (en) 2019-01-28 2020-01-28 Magnetic stents and stent delivery
PCT/US2020/015447 WO2020160013A1 (en) 2019-01-28 2020-01-28 Improved stent delivery for vascular surgery
US18/205,895 US20230310184A1 (en) 2019-01-28 2023-06-05 Magnetic stent and stent delivery

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962797933P 2019-01-28 2019-01-28
US201962797932P 2019-01-28 2019-01-28
US201962797944P 2019-01-28 2019-01-28
US16/752,315 US11666464B2 (en) 2019-01-28 2020-01-24 Magnetic stent and stent delivery
US16/752,343 US20200237540A1 (en) 2019-01-28 2020-01-24 Stent delivery for vascular surgery
US16/752,265 US20200237539A1 (en) 2019-01-28 2020-01-24 Stent and stent delivery for vascular surgery

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US16/752,343 Continuation-In-Part US20200237540A1 (en) 2019-01-28 2020-01-24 Stent delivery for vascular surgery
US16/752,265 Continuation-In-Part US20200237539A1 (en) 2019-01-28 2020-01-24 Stent and stent delivery for vascular surgery

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/752,265 Continuation-In-Part US20200237539A1 (en) 2019-01-28 2020-01-24 Stent and stent delivery for vascular surgery
US18/205,895 Continuation US20230310184A1 (en) 2019-01-28 2023-06-05 Magnetic stent and stent delivery

Publications (2)

Publication Number Publication Date
US20200237534A1 true US20200237534A1 (en) 2020-07-30
US11666464B2 US11666464B2 (en) 2023-06-06

Family

ID=71733146

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/752,315 Active US11666464B2 (en) 2019-01-28 2020-01-24 Magnetic stent and stent delivery

Country Status (1)

Country Link
US (1) US11666464B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200237540A1 (en) * 2019-01-28 2020-07-30 Spiros Manolidis Stent delivery for vascular surgery
US11666464B2 (en) 2019-01-28 2023-06-06 Tensor Flow Ventures Llc Magnetic stent and stent delivery

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141516A (en) * 1989-07-26 1992-08-25 Detweiler Mark B Dissolvable anastomosis stent and method for using the same
US6361559B1 (en) * 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
US20020143347A1 (en) * 2000-12-13 2002-10-03 Ventrica, Inc. Extravascular anastomotic components and methods for forming vascular anastomoses
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US20070067014A1 (en) * 2005-09-22 2007-03-22 Microport Medical Co., Ltd. Method for aortic graft installation
US20100262171A1 (en) * 2009-04-09 2010-10-14 Mao-Tsun Wu Endovascular Stent Insertion Method
US20140081415A1 (en) * 2010-12-07 2014-03-20 The Brigham And Women's Hospital, Inc. Microvascular anastomotic coupler and methods of using same
US20190239879A1 (en) * 2003-04-28 2019-08-08 Neograft Technologies, Inc. Graft apparatus
US20220273365A1 (en) * 2019-08-30 2022-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Nerve Repair Using Laser Sealing
US20220303150A1 (en) * 2021-03-16 2022-09-22 Zoom Video Communications, Inc Systems and methods for video conference acceleration

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054128A (en) 1976-09-28 1977-10-18 Universite De Sherbrooke Device for carrying observation and/or manipulation instruments
IT1235460B (en) 1987-07-31 1992-07-30 Confida Spa FLEXIBLE ENDOSCOPE.
US5349133A (en) 1992-10-19 1994-09-20 Electronic Development, Inc. Magnetic and electric field shield
US5368564A (en) 1992-12-23 1994-11-29 Angeion Corporation Steerable catheter
WO1994015549A1 (en) 1992-12-30 1994-07-21 Schneider (Usa) Inc. Apparatus for deploying body implantable stents
US5536236A (en) 1993-02-12 1996-07-16 Olympus Optical Co., Ltd. Covered endoscope system
DE69431989T2 (en) 1993-04-13 2003-11-06 Boston Scient Corp DEVICE FOR APPLYING A PROSTHESIS WITH A DILATION TIP
IL105828A (en) 1993-05-28 1999-06-20 Medinol Ltd Medical stent
US5573493A (en) 1993-10-08 1996-11-12 United States Surgical Corporation Endoscope attachment for changing angle of view
DE69419877T2 (en) 1993-11-04 1999-12-16 Bard Inc C R Fixed vascular prosthesis
US5492131A (en) 1994-09-06 1996-02-20 Guided Medical Systems, Inc. Servo-catheter
IL119189A0 (en) 1996-09-03 1996-12-05 Lev Shlomo Annulus catheter
US6565581B1 (en) 1996-09-16 2003-05-20 Origin Medsystems, Inc. Apparatus and method for performing an anastomosis
WO1998020810A1 (en) 1996-11-12 1998-05-22 Medtronic, Inc. Flexible, radially expansible luminal prostheses
US6406488B1 (en) 1998-08-27 2002-06-18 Heartstent Corporation Healing transmyocardial implant
AU768150B2 (en) 1999-01-22 2003-12-04 W.L. Gore & Associates, Inc. A biliary stent-graft
IT1307765B1 (en) 1999-02-05 2001-11-19 Pietro Quaretti TUBULAR ENDOPROTESIS, IN PARTICULAR FOR USE IN THE BURIAL URETERAL DUCTS, AS WELL AS IN THE ESOPHAGE.
DE60021917D1 (en) 1999-10-08 2005-09-15 Gen Hospital Corp Perkutane stentprothese
US6361556B1 (en) 2000-04-27 2002-03-26 Endovascular Tech Inc System and method for endovascular aneurysm repair in conjuction with vascular stabilization
US6699274B2 (en) 2001-01-22 2004-03-02 Scimed Life Systems, Inc. Stent delivery system and method of manufacturing same
US6863651B2 (en) 2001-10-19 2005-03-08 Visionscope, Llc Miniature endoscope with imaging fiber system
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US6699263B2 (en) 2002-04-05 2004-03-02 Cook Incorporated Sliding suture anchor
US8298161B2 (en) 2002-09-12 2012-10-30 Intuitive Surgical Operations, Inc. Shape-transferring cannula system and method of use
FR2845590B1 (en) 2002-10-10 2005-10-21 Jean Francois Garbe DEVICE FOR CONNECTION BETWEEN A PROSTHESIS AND A BODY CONDUIT AND DEVICE FOR CONNECTING TWO BODY CONDUITS DISPOSED AT END-TO-END
US6899672B2 (en) 2002-11-08 2005-05-31 Scimed Life Systems, Inc. Endoscopic imaging system including removable deflection device
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7220274B1 (en) 2003-03-21 2007-05-22 Quinn Stephen F Intravascular stent grafts and methods for deploying the same
US7090637B2 (en) 2003-05-23 2006-08-15 Novare Surgical Systems, Inc. Articulating mechanism for remote manipulation of a surgical or diagnostic tool
US7041127B2 (en) 2003-05-28 2006-05-09 Ledergerber Walter J Textured and drug eluting coronary artery stent
AU2004281704B2 (en) * 2003-10-10 2008-11-13 Cardiaq Valve Technologies, Inc. System and method for endoluminal grafting of bifurcated and branched vessels
WO2005060882A1 (en) 2003-12-09 2005-07-07 Gi Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US8046049B2 (en) 2004-02-23 2011-10-25 Biosense Webster, Inc. Robotically guided catheter
EP1793765B1 (en) 2004-09-28 2011-03-16 Cordis Corporation Thin film medical device and delivery system
US20090023998A1 (en) 2007-07-17 2009-01-22 Nitesh Ratnakar Rear view endoscope sheath
US20080249507A1 (en) 2004-12-01 2008-10-09 Vision - Sciences Inc. Emergency Electrode on Medical Tube
US8182422B2 (en) 2005-12-13 2012-05-22 Avantis Medical Systems, Inc. Endoscope having detachable imaging device and method of using
WO2007005976A1 (en) 2005-07-01 2007-01-11 Hansen Medical, Inc. Robotic catheter system
US8702789B2 (en) 2005-07-29 2014-04-22 Cvdevices, Llc Endoprosthesis assemblies and methods for using the same
US20080091169A1 (en) 2006-05-16 2008-04-17 Wayne Heideman Steerable catheter using flat pull wires and having torque transfer layer made of braided flat wires
US8409172B2 (en) 2006-08-03 2013-04-02 Hansen Medical, Inc. Systems and methods for performing minimally invasive procedures
WO2008025855A2 (en) 2006-09-01 2008-03-06 Zotz Rainer J Devices, system, kit and method for epicardial access
US8211025B2 (en) 2006-10-20 2012-07-03 General Electric Company Four-way steerable catheter system and method of use
JP5014436B2 (en) 2006-11-30 2012-08-29 ウィリアム・クック・ヨーロッパ・アンパルトセルスカブ Push-in sheath and placement device
US20080255653A1 (en) 2007-04-13 2008-10-16 Medtronic Vascular, Inc. Multiple Stent Delivery System and Method
GB2452480A (en) 2007-08-31 2009-03-11 Sentient Medical Ltd Surgical device having illuminating and imaging means
JP2009119064A (en) 2007-11-15 2009-06-04 Olympus Corp Cover type endoscope, endoscope for cover, and endoscope cover
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
US8454632B2 (en) 2008-05-12 2013-06-04 Xlumena, Inc. Tissue anchor for securing tissue layers
US20090287293A1 (en) * 2008-05-15 2009-11-19 Mailhot Jr Robert Magnetically induced radial expansion vascular stent
US9820746B2 (en) 2008-07-28 2017-11-21 Incube Laboratories LLC System and method for scaffolding anastomoses
GB0823716D0 (en) 2008-12-31 2009-02-04 Angiomed Ag Stent delivery device with rolling stent retaining sheath
CA2961053C (en) 2009-04-15 2019-04-30 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8444549B2 (en) 2009-04-16 2013-05-21 Covidien Lp Self-steering endoscopic device
US8512232B2 (en) 2009-09-08 2013-08-20 Gyrus Acmi, Inc. Endoscopic illumination system, assembly and methods for staged illumination of different target areas
EP4332989A3 (en) 2009-10-12 2024-05-01 Corindus, Inc. Catheter system with percutaneous device movement algorithm
CA2782357C (en) 2009-11-30 2018-06-05 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US20110190870A1 (en) 2009-12-30 2011-08-04 Boston Scientific Scimed, Inc. Covered Stent for Vascular Closure
EP2533722B1 (en) 2010-02-08 2017-03-29 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
DE102010012417B4 (en) 2010-03-23 2012-08-02 Gottfried Wilhelm Leibniz Universität Hannover Bending reactor and endoscope with a bending actuator
US9326870B2 (en) 2010-04-23 2016-05-03 Medtronic Vascular, Inc. Biodegradable stent having non-biodegradable end portions and mechanisms for increased stent hoop strength
US8623079B2 (en) 2010-04-23 2014-01-07 Medtronic, Inc. Stents for prosthetic heart valves
GB2485762B (en) 2010-11-12 2012-12-05 Cook Medical Technologies Llc Introducer assembly and dilator tip therefor
EP3321042A1 (en) 2011-09-13 2018-05-16 Medrobotics Corporation Highly articulated probes with anti-twist link arrangement
US10952732B2 (en) 2013-02-21 2021-03-23 Boston Scientific Scimed Inc. Devices and methods for forming an anastomosis
US9949692B2 (en) * 2012-12-21 2018-04-24 Canary Medical Inc. Stent graft monitoring assembly and method of use thereof
JP6356152B2 (en) 2013-01-24 2018-07-11 グラフトウォークス, インコーポレイテッド Device for measuring flow through a lumen
WO2014143730A1 (en) 2013-03-15 2014-09-18 Boston Scientific Scimed, Inc. Anti-migratory stent coating
GB2526265B (en) 2014-05-13 2016-08-17 Cook Medical Technologies Llc Medical device having magnetically expandable frame
US10500042B2 (en) 2014-05-22 2019-12-10 St. Jude Medical, Cardiology Division, Inc. Stents with anchoring sections
WO2015191859A2 (en) 2014-06-13 2015-12-17 The Regents Of The University Of California Sutureless anastomosis device
US20150366439A1 (en) 2014-06-24 2015-12-24 National Cheng Kung University Method of operating an endoscope by changing magnetic field and controlling feeding and rotation of the endoscope synchronously
CN104116484A (en) 2014-07-03 2014-10-29 乐虹信息科技(上海)有限公司 Endoscope system with adjustable shooting angle and method
EP3171790A1 (en) 2014-07-23 2017-05-31 GI Windows Inc. Magnetic anastomosis devices and methods of delivery
CN107148235B (en) 2014-09-10 2019-10-08 直观外科手术操作公司 Use the catheter tip of cooperation and device, the system and method for tool
CA2998709A1 (en) 2014-09-17 2016-03-24 Canary Medical Inc. Devices, systems and methods for using and monitoring medical devices
US10111741B2 (en) 2014-10-29 2018-10-30 W. L. Gore & Associates, Inc. Intralumenal stent graft fixation
US10130497B2 (en) 2015-02-20 2018-11-20 Boston Scientific Scimed, Inc. Stent with retractable anchors
US9943627B2 (en) 2015-03-03 2018-04-17 Yujie Zhou Method of producing personalized biomimetic drug-eluting coronary stents by 3D-printing
GB201508593D0 (en) * 2015-05-19 2015-07-01 Vascular Flow Technologies Ltd A stent
US10420661B2 (en) 2015-12-17 2019-09-24 Covidien Lp Stents and stent deployment devices
DE102016007669B4 (en) 2016-06-24 2019-07-11 Schölly Fiberoptic GmbH Endoscope protective cover with integrated heating element and method for heating an endoscope protective cover
EP4238490A3 (en) 2016-06-30 2023-11-01 Intuitive Surgical Operations, Inc. Graphical user interface for displaying guidance information during an image-guided procedure
US10636555B2 (en) 2016-08-22 2020-04-28 Seyed Mostafa Zareei Articulated video probe with magnetic stimulation
BE1024715B1 (en) 2016-10-10 2018-06-04 Filip Walter Nicole Haenen STENT
CN110022795B (en) 2017-02-24 2023-03-14 波顿医疗公司 Constrained stent grafts, delivery systems and methods of use
US11040441B2 (en) 2018-09-20 2021-06-22 Sony Group Corporation Situation-aware robot
US11083610B2 (en) 2019-01-08 2021-08-10 Covidien Lp Expandable stent delivery apparatus to cover an access site
US11666464B2 (en) 2019-01-28 2023-06-06 Tensor Flow Ventures Llc Magnetic stent and stent delivery
US20200237539A1 (en) 2019-01-28 2020-07-30 Spiros Manolidis Stent and stent delivery for vascular surgery
US20230026939A1 (en) 2021-07-26 2023-01-26 Tensor Flow Ventures Llc Dual stent and delivery system, delivery tool apparatus, and method of delivery of dual stents

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141516A (en) * 1989-07-26 1992-08-25 Detweiler Mark B Dissolvable anastomosis stent and method for using the same
US6361559B1 (en) * 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
US20020143347A1 (en) * 2000-12-13 2002-10-03 Ventrica, Inc. Extravascular anastomotic components and methods for forming vascular anastomoses
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US20190239879A1 (en) * 2003-04-28 2019-08-08 Neograft Technologies, Inc. Graft apparatus
US20070067014A1 (en) * 2005-09-22 2007-03-22 Microport Medical Co., Ltd. Method for aortic graft installation
US20100262171A1 (en) * 2009-04-09 2010-10-14 Mao-Tsun Wu Endovascular Stent Insertion Method
US8097009B2 (en) * 2009-04-09 2012-01-17 Mao-Tsun Wu Endovascular stent insertion method
US20140081415A1 (en) * 2010-12-07 2014-03-20 The Brigham And Women's Hospital, Inc. Microvascular anastomotic coupler and methods of using same
US20220273365A1 (en) * 2019-08-30 2022-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Nerve Repair Using Laser Sealing
US20220303150A1 (en) * 2021-03-16 2022-09-22 Zoom Video Communications, Inc Systems and methods for video conference acceleration

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200237540A1 (en) * 2019-01-28 2020-07-30 Spiros Manolidis Stent delivery for vascular surgery
US20200237539A1 (en) * 2019-01-28 2020-07-30 Spiros Manolidis Stent and stent delivery for vascular surgery
US11666464B2 (en) 2019-01-28 2023-06-06 Tensor Flow Ventures Llc Magnetic stent and stent delivery

Also Published As

Publication number Publication date
US11666464B2 (en) 2023-06-06

Similar Documents

Publication Publication Date Title
US20230310184A1 (en) Magnetic stent and stent delivery
Porter et al. Porter
USRE47154E1 (en) Device and method for vascular access
AU2006280222B2 (en) Methods and devices for deployment of tissue anchors
US11666464B2 (en) Magnetic stent and stent delivery
EP2839796A1 (en) Endovascular delivery system for magnetic compression vascular anastomosis
US20030125790A1 (en) Deployment device, system and method for medical implantation
EP1791477A2 (en) Improved device and method for vascular access
US20220370700A1 (en) Device and Method for Atraumatic and Percutaneous Formation of an Arteriovenous Fistula
JP2019107527A (en) Surgical procedure and devices for use therein
US10499920B2 (en) Anchor device for vascular anastomosis
WO2019089569A1 (en) Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US20050043708A1 (en) Anastomosis device and method
US20220110635A1 (en) Implantable medical device including valve member
US9301838B2 (en) Apparatus and method for delivering a structure to a desired target site
US20230026939A1 (en) Dual stent and delivery system, delivery tool apparatus, and method of delivery of dual stents
JP2011524188A (en) Anastomosis instrument

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

AS Assignment

Owner name: TENSOR FLOW VENTURES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MANOLIDIS, SPIROS;REEL/FRAME:056738/0936

Effective date: 20200518

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

AS Assignment

Owner name: TENSOR FLOW VENTURES LLC, TEXAS

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 16725315 PREVIOUSLY RECORDED AT REEL: 056738 FRAME: 0936. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:MANOLIDIS, SPIROS;REEL/FRAME:061877/0051

Effective date: 20200518

STCF Information on status: patent grant

Free format text: PATENTED CASE